Literature DB >> 24215268

Canine antimicrobial peptides are effective against resistant bacteria and yeasts.

Domenico Santoro1, Carol W Maddox.   

Abstract

BACKGROUND: Antimicrobial peptides (AMPs) are small proteins present in most living species and they are involved in the defence against pathogenic organisms. β-Defensins and cathelicidin are the most frequently studied AMPs in both people and dogs. HYPOTHESIS/
OBJECTIVES: Our objectives were to determine the minimal inhibitory concentration and minimal bactericidal concentration of two canine β-defensins and a cathelicidin against antibiotic-sensitive and antibiotic-resistant bacteria and yeasts using a broth microdilution method.
METHODS: The micro-organisms tested were ATCC strains of meticillin-sensitive and meticillin-resistant Staphylococcus aureus (MSSA and MRSA, respectively), meticillin-sensitive Staphylococcus pseudintermedius (MSSP), Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Malassezia pachydermatis. Field strains of meticillin-resistant S, pseudintermedius (MRSP, n = 1) and MSSP (n = 11) were also tested. Mann-Whitney U-test and Friedman test were used for statistical analysis.
RESULTS: The MSSP and MRSP were more susceptible to canine AMPs than MSSA and MRSA. Malassezia pachydermatis was more sensitive than C. albicans to canine AMPs. The β-defensin cBD103 was most effective against Staphylococci and P. aeruginosa, while the cathelicidin cCath was the most effective AMP against E. coli. Additionally, cBD103 was the most effective AMP for both yeasts studied, with M. pachydermatis being more susceptible than C. albicans. All AMPs tested exhibited killing within 2 h of exposure. CONCLUSIONS AND CLINICAL IMPORTANCE: We demonstrated that natural canine AMPs are effective against canine-specific pathogens, are equally effective against meticillin-resistant or -susceptible strains, and are more effective against M. pachydermatis than against C. albicans organisms.
© 2013 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24215268     DOI: 10.1111/vde.12091

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  4 in total

1.  Evaluation of the effects of chlorhexidine digluconate with and without cBD103 or cCath against multidrug-resistant clinical isolates of Staphylococcus pseudintermedius.

Authors:  Domenico Santoro; Lopamudra Kher; Vanessa Chala; Christelle Navarro
Journal:  Vet Dermatol       Date:  2021-09-06       Impact factor: 1.867

2.  Effect of Nanosulfur Against Multidrug-Resistant Staphylococcus pseudintermedius and Pseudomonas aeruginosa.

Authors:  Lopamudra Kher; Domenico Santoro; Karen Kelley; Daniel Gibson; Gregory Schultz
Journal:  Appl Microbiol Biotechnol       Date:  2022-04-06       Impact factor: 5.560

3.  Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs.

Authors:  Mohamed F Mohamed; G Kenitra Hammac; Lynn Guptill; Mohamed N Seleem
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

4.  Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections.

Authors:  Ines Greco; Agnete Plahn Emborg; Bimal Jana; Natalia Molchanova; Alberto Oddo; Peter Damborg; Luca Guardabassi; Paul R Hansen
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.